Monthly Archives: April 2017

DV Resources Ltd. Announces Change of Board of Directors

VANCOUVER, BC / ACCESSWIRE / April 27, 2017 / DV Resources Ltd. (TSX-V: DLV.H) (the “Company”) is pleased to announce that Peter Leitch, Geir Liland and Larry Copeland have been appointed to the Company’s board of directors and that the Company has appointed Geir Liland as Chief Executive Officer and Melinda Coghill as Chief Financial Officer and Corporate Secretary. Carl Jonsson, Theo Sanidas, and Thomas Wharton have resigned from the board and the board would like to thank them for their services.

The Company has also entered into a financial advisory mandate agreement with Fiore Management & Advisory Corp. to provide financial advice and corporate administration.

The Company also announces that Brian Paes-Braga acquired 7,000,000 common shares pursuant to a private transaction. The acquisitions represent 20.58% of the issued and outstanding common shares of the Company. As a result of the acquisition of securities described above, Brian Paes-Braga directly and indirectly, owns and or controls, in aggregate 7,000,000 common shares of the Issuer, representing 20.58% of the current issued and outstanding common shares of the Company.

The Company has been advised that Mr. Paes-Braga acquired these securities for investment purposes and, as disclosed in the Early Warning Report accompanying this news release, may in the future acquire or dispose of securities of the Company, through the market, privately or otherwise, as circumstances or market conditions warrant.

On behalf of DV RESOURCES LTD.

“Geir Liland”
Chief Executive Officer

For further information, please contact:

Melinda Coghill
CFO & Corporate Secretary
Tel: (604) 609-6148

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: DV Resources Ltd.

ReleaseID: 460898

Curlew Announces Proposed Consolidation and Financing up to $1,000,000

VANCOUVER, BC / ACCESSWIRE / April 27, 2017 / Curlew Lake Resources Inc. (TSX-V: CWQ) (OTC PINK: CWLXF) announces that it will be implementing a consolidation of the Company’s share capital on a ten (10) old shares for one (1) new share basis. The Company currently has 19,792,220 shares outstanding, which, if no further shares are issued, would be reduced to 1,979,222 post-consolidated common shares. There will be no name change with this consolidation. The Company will disseminate a further News Release upon acceptance from the Exchange which will set out the Effective Date for the consolidation.

Additionally, the Company has negotiated, subject to acceptance by the Exchange (“NEX”), a private placement and debt settlement with certain creditors for outstanding debts for total gross proceeds of up to $1,000,000 (the “Financing”). Upon receipt of acceptance from the TSX-V to the Financing, the Company will issue up to 4,000,000 common shares (the “Shares”) at a price of $0.25 per Share. Proceeds raised from the Financing will be used towards general working capital purposes and looking for new business.

All the independent directors of the Company, acting in good faith, have determined that the fair market value of the securities being issued and the consideration paid is reasonable and is exempt from the formal valuation and minority shareholder approval requirements of Multilateral Instrument 61-101.

ON BEHALF OF THE BOARD

SIGNED: “Christopher Cherry”

Christopher Cherry, CFO and Secretary

For more information, contact:

Christopher Cherry
Tel: (604) 908-3095
Website: www.curlew-lake.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Information

The news release includes certain “forward-looking statements”. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding potential mineralization, exploration results and future plans and objectives of the Company are forward-looking statements that involve various risks and uncertainties. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including the assumptions that the conditions precedent to completion of the Financing will be fulfilled in a timely manner; all necessary approvals and consents in respect of the consolidation, Debt Settlement and Financing will be obtained in a timely manner and on acceptable terms; and general business and economic conditions will not change in a materially adverse manner. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include market prices, exploitation and exploration results, availability of capital and financing, general economic, market or business conditions, uninsured risks, regulatory changes, availability of personnel, unanticipated exploration risks detailed herein and from time to time in the filings made by the Company with securities regulators. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise except as otherwise required by applicable securities legislation.

SOURCE: Curlew Lake Resources Inc.

ReleaseID: 460899

FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Graña y Montero S.A.A. (GRAM) and Lead Plaintiff Deadline: April 28, 2017

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Graña y Montero S.A.A. (“Grañ” or the “Company”) (NYSE: GRAM) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Graña securities between April 30, 2014 through February 24, 2017, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/gram.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed that: (1) Graña was aware that its Brazilian partner, Odebrecht S.A., paid bribes to former Peruvian President Alejandro Toledo to win construction work on a road traveling from Peru to Brazil; and (2) consequently, defendants’ statements about Graña’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On February 24, 2017, local news magazine Hildebrandt en sus trece revealed that Graña y Montero was aware of $20 million in bribes conferred to former President Alejandro Toledo by Brazilian firm, Odebrecht SA. Graña was one of Odebrecht’s local partners on two sections of a project to pave a road from the Peruvian Amazon to Brazil. Following this news, Graña shares dropped $1.77 per share, or over 34%, to close $3.32 on February 24, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/gram, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Graña y Montero S.A.A., you have until April 28, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 460680

INVESTOR REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against JBS S.A. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 27, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against JBS S.A. (“JBS” or the “Company”) (OTCQX: JBSAY) concerning possible violations of federal securities laws between June 2, 2015 and March 17, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the May 22, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The Complaint alleges that throughout the Class Period, JBS made false and/or misleading statements and/or failed to disclose that its executives bribed regulators and politicians to subvert food inspections of its plants and overlook unsanitary practices, such as processing rotten meat and running plants with traces of salmonella.

On March 17, 2017, reports emerged that Brazilian federal police raided the offices of JBS and dozens of other meatpackers following a two-year investigation into alleged bribery of regulators to subvert inspections of their plants and overlook unsanitary practices. Police arrested two JBS employees, among others. JBS stated in a securities filing that three of its plants and one of its employees were targeted in the probe. When this information reached the public, JBS’ stock price fell materially, which harmed investors according to the Complaint.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 460895

DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Omega Protein Corporation and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 27, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Omega Protein Corporation (“Omega” or the “Company”) (NYSE: OME). Investors, who purchased or otherwise acquired the Company’s shares between August 3, 2016 and March 1, 2017 inclusive (the “Class Period”), are encouraged to contact the firm prior to the May 1, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The Complaint alleges that throughout the Class Period, Omega made false and/or misleading statements and/or failed to disclose that: the SEC is requesting information for an investigation relating to the Company subsidiary’s compliance with its probation terms and Omega’s protection of whistleblower employees; that it is possible that the foregoing matter could have a material adverse effect on Omega’s business, reputation, results of operation and financial condition; and that as a result of the above, the Company’s statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When this news was released, Omega’s stock price dropped significantly, which harmed investors according to the Complaint.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
https://lundinlawpc.com

SOURCE: LundinLaw PC

ReleaseID: 460893

Aerojet Rocketdyne to Leave Thousands Jobless (AJRD)

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Warnact.com reports that Aerojet Rocketdyne, Inc.’s (NYSE: AJRD) Sacramento location will cut over 1,100 jobs over the next year and a half. The rocket engine maker plans to relocate or cut positions in that facility and move jobs to Alabama, Canoga Park and other locations. Aerojet Rocketdyne’s Sacramento location currently employs 1,400 people. After the job changes, that facility will house shared services for the entire company, including issues related to the supply chain, finance and human resources.

Eileen Drake, Aerojet Rocketdyne’s Chief Execuctive Officer, says that these changes are the next phase of a multiyear plan initiated in 2015 to reduce costs and increase operational efficiency, and that these changes will move “common work with common facilities.” As part of this plan, Aerojet Rocketdyne’s Gainesville, Va., engineering facility, will close next year, and about 170 jobs will either be eliminated or relocated to Huntsville or another facility in Virginia.

The Los Angeles Times tells us by the end of 2018, defense-related program management, engineering and related support positions in Sacramento will move to Huntsville, Ala., where the company’s defense business unit is based. Huntsville is also the final assembly site for Aerojet Rocketdyne’s new AR1 rocket engine. All Sacramento based jobs in specifically the space programs are moving to Canoga Park, where a space headquarters has been built, as the company plans to develop several different kinds of rocket engines.

It is reported that this multiyear plan is expected to save the company around $230 million per year, whereas the consolidations in Sacramento and Gainesville will save about $85 million.

The company’s CFO, Paul Lundstrom, has said that the company has not yet determined the exact number of jobs that would be moving to the various locations or be eliminated, but the employees who are laid off will receive a severance package.

According to the law firm of Levi & Korsinsky LLP, an employee advocacy firm, similar mass layoffs may result in employment law violations. For example, the WARN Act is a United States labor law that protects employees of businesses with 100 or more employees. If an employer conducts a plant closing or mass layoff affecting 50 or more employees, who constitute at least 33% of the employees at that site, or more than 500 employees, the employer must provide 60 days’ advance notification. Employees are therefore entitled to full pay and benefits during such period prior to layoff and may also be entitled to various other protections under the law.

Notably, several states have enacted their own “mini-WARN Acts” with generally more stringent requirements. With regards to this particular case, California has implemented the Cal-WARN Act, which applies to any private business with 75 or more full- or part-time employees who have been employed at the business for at least 6 of the 12 months preceding the date notice was required. Under the Cal-WARN Act, 60 days’ advance notice is required to be given by the employer when closing a plant, laying off a substantial number of employees, or relocating their business.

Levi & Korsinsky believes that Zenefits might have violated the WARN Act, and/or the Cal-WARN Act, and believe affected individuals may be entitled to back wages and benefits from the company.

The advance notice is intended to give employees and their families transition time to adjust to the prospective loss of employment, to seek and to obtain other employment, and, if necessary, to enter skill training or retraining programs that will allow these workers to successfully compete in the job market. Oftentimes, employees don’t receive the benefits they are due or are otherwise harmed during the layoff process and may have recourse under the law.

For more information about the WARN Act and other employee rights, contact:

Levi
& Korsinsky, LLP

www.WARNact.com
877-363-5972

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 460894

Atrium Mortgage Investment Corporation Announces Election of Directors

TORONTO, ON / ACCESSWIRE / April 27, 2017 / Atrium Mortgage Investment Corporation (TSX: AI) (TSX: AI.DB) (TSX: AI.DB.A) (TSX: AI.DB.B) (OTC PINK: AMIVF) today announced that at its annual meeting of shareholders, held in Toronto earlier today, each of the seven director nominees listed in its management information circular dated March 6, 2017 was elected as a director. Directors have been elected to serve until the close of the next annual meeting of shareholders. The detailed results of the vote for the election of directors of Atrium is set out below:

Nominee
Votes For*
% Votes For
Votes Withheld*
% Votes Withheld
Peter P. Cohos
6,083,259
99.98%
1,151
0.02%
Robert H. DeGasperis
6,047,769
99.40%
36,641
0.60%
Robert G. Goodall
5,034,225
82.74%
1,050,185
17.26%
Andrew Grant
6,081,559
99.95%
2,851
0.05%
Nancy H.O. Lockhart
6,081,459
99.95%
2,951
0.05%
David M. Prussky
6,082,459
99.97%
1,951
0.03%
Mark L. Silver
6,082,459
99.97%
1,951
0.03%

* As a vote for each motion was taken by a show of hands, the number of votes disclosed reflects only those proxies received by management in advance of the meeting.

About Atrium

Canada’s Premier Non-Bank Lender™

Atrium is a non-bank provider of residential and commercial mortgages that lends in major urban centres in Canada where the stability and liquidity of real estate are high. Atrium’s objectives are to provide its shareholders with stable and secure dividends and preserve shareholders’ equity by lending within conservative risk parameters.

Atrium is a Mortgage Investment Corporation (MIC) as defined in the Income Tax Act (Canada), so is not taxed on income provided that its taxable income is paid to its shareholders in the form of dividends within 90 days after December 31 each year. Such dividends are generally treated by shareholders as interest income, so that each shareholder is in the same position as if the mortgage investments made by the company had been made directly by the shareholder. For further information, please refer to regulatory filings available at www.sedar.com or Atrium’s website at www.atriummic.com.

For further information, please contact:

Robert G. Goodall
President and Chief Executive Officer

Jeffrey D. Sherman
Chief Financial Officer

(416) 867-1053
info@atriummic.com
www.atriummic.com

SOURCE: Atrium Mortgage Investment Corporation

ReleaseID: 460891

Fatty Liver Disease Market Pipeline 2017 Industry Share for Novartis, Celgene, NGM Biopharmaceuticals, and Others

Fatty Liver Disease Therapeutics Market report provides the composition of the FLD market in terms of dominant classes of therapies. Key unmet needs are identified to allow a competitive understanding of gaps in the market.

April 27, 2017 /MarketersMedia/

The report “Frontier Pharma: Fatty Liver Disease Pipeline Market – High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products” helps to understand the current clinical and commercial landscapes by considering disease pathogenesis, etiology, epidemiology, symptoms, co-morbidities and complications, and treatment options and algorithms.

Browse the Fatty Liver Disease Pipeline Market 2017 Report of 76 Pages, 58 Tables and Figures, and 10 Companies Available at http://www.reportsnreports.com/contacts/discount.aspx?name=974419.

Fatty liver disease (FLD) Market comprises a spectrum of chronic liver disorders characterized by excessive lipid accumulation in the liver (steatosis), which may lead to inflammation (steatohepatitis) and fibrosis. It has the potential to progress to end-stage liver diseases such as cirrhosis, liver cancer and liver failure. It is also associated with numerous complications and co-morbidities, including cardiovascular and metabolic diseases. FLD can be divided into non-alcoholic FLD (NAFLD) and alcoholic FLD (AFLD), depending on the history of alcohol use. Both can also be divided into two subgroups: steatosis and steatohepatitis.

This Report Covered Below Points
• Provides the composition of the FLD market in terms of dominant classes of therapies. Key unmet needs are identified to allow a competitive understanding of gaps in the market.
• Allows recognizing innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix tailored to FLD, all first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Promising early-stage targets have been further reviewed in greater detail.

Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=974419.
Companies mentioned in this report: Novartis, Celgene, NGM Biopharmaceuticals, Raptor Pharmaceuticals, chemomAb, Conatus Pharmaceuticals, BLR Bio.

Scope of the Report
FLD comprises a diverse patient population with significant unmet needs
The FLD pipeline is relatively large and has a high degree of first-in-class innovation
The FLD deal landscape shows rising deal volumes and considerable investment opportunities

List of Tables
Table 1: Fatty Liver Disease Therapeutics Market, Survival Rates of Simple Steatosis and NASH/ASH, 2017
Table 2: Fatty Liver Disease Therapeutics Market, Global, Key Features and Pipeline Activity of Connective Tissue Growth Factor, 2017
Table 3: Fatty Liver Disease Therapeutics Market, Global, Pipeline Programs Targeting Connective Tissue Growth Factor, 2017
Table 4: Fatty Liver Disease Therapeutics Market, Global, Key Features and Pipeline Activity of Sterol Regulatory Element-Binding Protein 1, 2017
Table 5: Fatty Liver Disease Therapeutics Market, Global, Key Features and Pipeline Activity of Sterol Regulatory Element-Binding Protein 2, 2017
And More…

List of Figures
Figure 1: Fatty Liver Disease Therapeutics Market, US, Innovation Trends in Product Approvals, Number of Product Approvals by FDA and Five-Year Moving Average of Product Approvals, 1987-2014
Figure 2: Fatty Liver Disease Therapeutics Market, Sales Performance of First-in-Class and Non-First-in-Class Products Post Marketing Approval ($m), 2006-2013
Figure 3: Fatty Liver Disease Therapeutics Market, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2017
Figure 4: Fatty Liver Disease Therapeutics Market, Global, Pipeline by Stage of Development and Molecule Type, 2017
And More…

In Depth Table of Content for Frontier Pharma: Fatty Liver Disease – High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Info:
Name: Ritesh Tiwari
Email: sales@reportsandreports.com
Organization: ReportsnReports.com
Phone: + 1 888 391 5441

Source URL: http://marketersmedia.com/fatty-liver-disease-market-pipeline-2017-industry-share-for-novartis-celgene-ngm-biopharmaceuticals-and-others/191499

For more information, please visit http://www.reportsnreports.com/reports/974419-frontier-pharma-fatty-liver-disease-high-degree-of-first-in-class-innovation-dominated-by-nuclear-receptor-targeting-nash-products.html

Source: MarketersMedia

Release ID: 191499

The Insight Partners: Global SaaS based SCM Market to grow with CAGR of 22.6% by 2025

Increased awareness of Shared Infrastructure Model Coupled with rising use of Big Data Analytics in organizations to boost the SaaS based SCM Market at a CAGR of 22.6%

April 27, 2017 /MarketersMedia/

In the era of automation, programmed machineries play a vital role in reducing cost and time taken to produce goods or to cater services. The users of applications are enabled to have more control over the sensitive data with features like 24/7 monitoring and security. Rapid digitization has added pressures on the organizations today to rely on cloud based applications. A cloud based application can be used to easily scale up or scale down the operations as per the demand being currently witnessed in the market. It handles flexibility to the application users. Flexibility offered by the SaaS model for SCM applications gives competitive advantage to users by letting them to quickly adjust to the demands of their respective customers and incorporate the necessary changes in the operations efficiently. Users derive high efficiency through this with reduced cost pressures that makes them highly competitive in the market. SaaS has been integrated by major upcoming and leading SCM software companies with major adoptions witnessed by the SME’s. The advantage offered is the faster responsiveness to the rapidly changing customer demands.

Browse market data tables and in-depth TOC of the SaaS based SCM Market to 2025 @ http://www.theinsightpartners.com/reports/saas-based-scm-market

The global SaaS based SCM market is segmented based on deployment model as: private cloud, public cloud, and hybrid cloud. The SaaS based SCM market can be further divided by solutions into manufacturing Planning, Sourcing and Procurement, Supply Chain Planning, Warehouse Management, Transportation Management and Others (S&OP, Import/ Export Planning, EDI, Demand Planning). Various industry verticals are into adoptions of the SaaS based SCM solutions and they can be classified as Transportation & Logistics services, Manufacturing industry, Retail industry, public sector, and distribution industry. On the basis of end-user SaaS based SCM market can be further divided into small & medium enterprises (SMEs), and large enterprises.

The global SaaS based SCM market is estimated to grow at a CAGR of 22.6% during the forecast period 2016 – 2025 and accounts for US$ 36.72 Bn in the year 2025. In case of a centralized on-premise supply chain management solution for a large organization, if there is some problem at the central server, there can be a catastrophic loss to the entire data, while in case of cloud based service, the data is processed from servers to servers at a very fast speed. Even if one server collapses, there are other servers that ensure the continuity of the operations and thus reducing the downtime of services. Realizing the cost efficiencies, redundant services and the need to cater to ever increasing demands, customers are steadily making a shift to cloud based supply chain services.

Request Sample Copy @ http://www.theinsightpartners.com/sample/TIPTE100000370

Each customer has become a separate segment today. Demands of any customer rapidly change today and companies offering services to them have to respond quickly. Survival in a highly dynamic environment requires quick response and that is provided by SCM software. These factors have led to increased adoptions of SaaS based SCM software. IBM Corporation, Oracle Corporation, SAP SE, Descartes Systems, Infor, JDA Software, Epicor, Manhattan Associates, Kewill and HighJump Software are some of the major players in the global SaaS based SCM market.

The report segments the global SaaS based SCM market as follows:

Global SaaS based SCM Market – By Deployment Model
• Private Cloud
• Public Cloud
• Hybrid Cloud

Global SaaS based SCM Market – By Solutions
• Manufacturing Planning
• Sourcing and Procurement
• Supply Chain Planning
• Warehouse Management
• Transportation Management
• Others (S&OP, Import/ Export Planning, EDI, Demand Planning)

Global SaaS based SCM Market – By Industry Verticals
• Transportation & Logistics Services
• Manufacturing
• Retail
• Public Sector
• Distribution

Global SaaS based SCM Market – By End-user
• Small & Medium Enterprises (SMEs)
• Large Enterprises

Global SaaS based SCM Market – By Geography
• North America
• Europe
• Asia Pacific (APAC)
• Middle East & Africa (MEA)
• South America (SAM)

Procure Full Report @ http://www.theinsightpartners.com/buy/TIPTE100000370

About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, and Telecommunication industries.

Contact Info:
Name: Sameer Joshi
Email: sales@theinsightpartners.com
Organization: The Insight Partners
Address: Pune, India
Phone: +1-646-491-9876

Source URL: http://marketersmedia.com/the-insight-partners-global-saas-based-scm-market-to-grow-with-cagr-of-22-6-by-2025/191319

For more information, please visit http://www.theinsightpartners.com/

Source: MarketersMedia

Release ID: 191319

CGI INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Celadon Group Inc. and a Lead Plaintiff Deadline of June 19, 2017

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the U.S. District Court for the Southern District of New York on behalf of investors who purchased Celadon Group Inc. (“Celadon Group”) (NYSE: CGI) securities between December 30, 2016 and April 18, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sa/celadon-group-inc?wire=1. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) CGI’s equity contribution to its joint venture with Element Financial Corp. was $68.2 million, rather than the $100 million contribution the Company reported in its public filings; (ii) the Company is being actively investigated by the SEC; and (iii) that as a result of the foregoing, CGI’s publicly disseminated financial statements were materially false and misleading.

On April 5, 2017, a report issued by Prescience Point Research Group charged that “CGI has used off-balance sheet entities…and manipulative accounting practices to hide its insolvent condition from investors and creditors.” Then, on April 19, 2017, Prescience Point Research published another report in which they provided correspondence from the SEC indicating that CGI was under investigation.

If you suffered a loss in Celadon Group, you have until June 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/celadon-group-inc?wire=1.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 460830